Ethylmalonic acid modulates Na+, K+-ATPase activity and mRNA levels in rat cerebral cortex

Synapse

Volumn 67, Issue 3, 2013, Pages 111-117

  Schuck, Patrícia Fernanda ^a   De Assis, Dênis Reis ^b   Viegas, Carolina Maso ^c   Brandão Pereira, Talita Carneiro ^d   Machado, Jéssica Luca ^a   Furlanetto, Camila Brulezi ^a   Bogo, Mauricio Reis ^d   Streck, Emilio Luiz ^a   Ferreira, Gustavo Costa ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Brain; Ethylmalonic acid; Na+,K+ ATPase; Short chain acyl CoA dehydrogenase deficiency

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DICARBOXYLIC ACID; ETHYLMALONIC ACID; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CEREBRAL CORTEX; MALE; MALONATES; PHOSPHORYLATION; RATS; RATS, WISTAR; RNA, MESSENGER; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRANSCRIPTION, GENETIC;

EID: 84872601991     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21618     Document Type: Article

References (49)

1. Aperia A. 2007. New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target. J Intern Med 261: 44-52.
2. Barschak AG, Ferreira G da C, André KR, Schuck PF, Viegas CM, Tonin A, Dutra Filho CS, Wyse AT, Wannmacher CM, Vargas CR, Wajner M. 2006. Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. Metab Brain Dis 21: 11-19.
3. Bavaresco CS, Chiarani F, Wannmacher CM, Netto CA, Wyse AT. 2007. Intrastriatal hypoxanthine reduces Na(+), K (+)-ATPase activity and induces oxidative stress in the rats. Metab Brain Dis 22: 1-11.
4. Beguin P, Beggah AT, Chibalin AV, Burgener-Kairuz P, Jaisser F, Mathews PM, Rossier BC, Cotecchia S, Geering K. 1994. Phosphorylation of the Na, K-ATPase alpha-subunit by protein kinase A and C in vitro and in intact cells. Identification of a novel motif for PKC-mediated phosphorylation. J Biol Chem 269: 24437-24445.
5. Benarroch EE. 2011. Heat shock proteins: Multiple neuroprotective functions and implications for neurologic disease. Neurology 76: 660-667.
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. 2+-stimulated ATPase activity. Anal Biochem 157: 375-380.
8. Cox B, Kislinger T, Emili A. 2005. Integrating gene and protein expression data: Pattern analysis and profile mining. Methods 35: 303-314.
9. de Assis DR, Ribeiro CA, Rosa RB, Schuck PF, Dalcin KB, Vargas CR, Wannmacher CM, Dutra-Filho CS, Wyse AT, Briones P, Wajner M. 2003. Evidence that antioxidants prevent the inhibition of Na(+), K(+)-ATPase activity induced by octanoic acid in rat cerebral cortex in vitro. Neurochem Res 28: 1255-1263.
10. + ATPase activity is markedly reduced by cis-4 decenoic acid in synaptic plasma membranes from cerebral cortex of rats. Exp Neurol 197: 143-149.
11. Ding C, Lu M, Huang J. 2011. Na(+)/K(+)-ATPase in the lacrimal glands of rabbits and its changes during induced autoimmune dacryoadenitis. Mol Vis 17: 2368-2379.
12. Durmaz R, Ertilav K, Akyuz F, Kanbak G, Bildirici K, Tel E. 2003. Lazaroid U-74389G attenuates edema in rat brain subjected to post-ischemic reperfusion injury. J Neurol Sci 215: 87-93.
13. Ebrahimi M, Roudkenar MH, Imani Fooladi AA, Halabian R, Ghanei M, Kondo H, Nourani MR. 2010. Discrepancy between mRNA and protein expression of neutrophil gelatinase-associated lipocalin in bronchial epithelium induced by sulfur mustard. J Biomed Biotechnol 2010: 823131.
14. Ferreira GC, André KR, Schuck PF, Viegas CM, Tonin A, Coelho DM, Wyse AT, Wannmacher CM, Vargas CR, Wajner M. 2006. Effect of in vivo administration of ethylmalonic acid on energy metabolism in rat tissues. Metab Brain Dis 21: 29-39.
15. Ferreira AG, Stefanello FM, Cunha AA, da Cunha MJ, Pereira TC, Bonan CD, Bogo MR, Netto CA, Wyse AT. 2011. Role of antioxidants on Na(+), K (+)-ATPase activity and gene expression in cerebral cortex of hyperprolinemic rats. Metab Brain Dis 26: 141-147.
16. Feschenko MS, Sweadner KJS. 1995. Structural basis for species-specific differences in the phosphorylation of Na, K-ATPase by protein kinase C. J Biol Chem 270: 14072-14077.
17. García-Silva MT, Ribes A, Campos Y, Garavaglia B, Arenas J. 1997. Syndrome of encephalopathy, petechiae, and ethylmalonic aciduria. Pediatr Neurol 17: 165-170.
18. Giordano C, Viscomi C, Orlandi M, Papoff P, Spalice A, Burlina A, Di Meo I, Tiranti V, Leuzzi V, d'Amati G, Zeviani M. 2012. Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis 35: 451-458.
19. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, Hood L, Aebersold R. 2002. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1: 323-333.
20. Hack CJ. 2004. Integrated transcriptome and proteome data: The challenges ahead. Brief Funct Genomic Proteomic 3: 212-219.
21. Hattori N, Kitagawa K, Higashida T, Yagyu K, Shimohama S, Wataya T, Perry G, Smith MA, Inagaki C. 1998. CI-ATPase and Na(+)/K(+)-ATPase activities in Alzheimer's disease brains. Neurosci Lett 254: 141-144.
22. Huang W, Lai CC, Wang Y, Askari A, Klevay LM, Askari A, Chiu TH. 1995. Altered expressions of cardiac Na/K-ATPase isoforms in copper deficient rats. Cardiovasc Res 29: 563-568.
23. Jones DH, Matus AI. 1974. Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim Biophys Acta 356: 276-287.
24. Jorgensen PL, Pedersen PA. 2001. Structure-function relationships of Na(+), K(+), ATP, or Mg(2+) binding and energy transduction in Na, K-ATPase. Biochim Biophys Acta 1505: 57-74.
25. Keseler IM, Collado-Vides J, Gama-Castro S, Ingraham J, Paley S, Paulsen IT, Peralta-Gil M, Karp PD. 2005. EcoCyc: A comprehensive database resource for Escherichia coli. Nucleic Acids Res 33: 334-337.
26. Khishna S, Andersson AM, Semsey S, Sneppen K. 2006. Structure and function of negative feedback loops at the interface of genetic and metabolic networks. Nucleic Acids Res 34: 2455-2462.
27. Leipnitz G, Schuck PF, Ribeiro CA, Dalcin KB, Assis DR, Barschak AG, Pulrolnik V, Wannmacher CM, Wyse AT, Wajner M. 2003. Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro. Neurochem Res 28: 771-777.
28. +-ATPase affects its conformational equilibrium. Proc Natl Acad Sci USA 93: 9132-9137.
29. Moseley AE, Williams MT, Schaefer TL, Bohanan CS, Neumann JC, Behbehani MM, Vorhees CV, Lingrel JB. 2007. Deficiency in Na, K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci 27: 616-626.
30. Palmfeldt J, Vang S, Stenbroen V, Pavlou E, Baycheva M, Buchal G, Monavari AA, Augoustides-Savvopoulou P, Mandel H, Gregersen N. 2011. Proteomics reveals that redox regulation is disrupted in patients with ethylmalonic encephalopathy. J Proteome Res 10: 2389-2396.
31. Papadopoulos MC, Lamb FJ, Moss RF, Davies DC, Tighe D, Bennett ED. 1999. Fecal peritonitis causes edema and neuronal injury in pig cerebral cortex. Clin Sci (Colch) 96: 461-466.
32. Pedersen CB, Zolkipli Z, Vang S, Palmfeldt J, Kjeldsen M, Stenbroen V, Schmidt SP, Wanders RJ, Ruiter JP, Wibrand F, Tein I, Gregersen N. 2010. Antioxidant dysfunction: Potential risk for neurotoxicity in ethylmalonic aciduria. J Inherit Metab Dis 33: 211-222.
33. Petrushanko IY, Yakushev S, Mitkevich VA, Kamanina YV, Ziganshin RH, Meng X, Anashkina AA, Makhro A, Lopina OD, Gassmann M, Makarov AA, Bogdanova A. 2012. S-glutathionylation of the Na, K-ATPase catalytic α subunit is a determinant of the enzyme redox-sensitivity. J Biol Chem 287: 32195-32205.
34. Roe CR, Ding J. 2001. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. p 1909-1963.
35. Salgado H, Santos-Zavaleta A, Gama-Castro S, Millan-Zarate D, Diaz-Peredo E, Sanchez Solano F, Perez-Rueda E, Bonavides-Martinez C, Collado-Vides J, Regulon DB. 2001. RegulonDB (version 3.2): Transcriptional regulation and operon organization in Escherichia coli K-12. Nucleic Acids Res 29: 72-74.
36. Schuck PF, Leipnitz G, Ribeiro CA, Dalcin KB, Assis DR, Barschak AG, Pulrolnik V, Wannmacher CM, Wyse AT, Wajner M. 2002. Inhibition of creatine kinase activity in vitro by ethylmalonic acid in cerebral cortex of young rats. Neurochem Res 27: 1633-1639.
37. Schuck PF, Ferreira G da C, Viegas CM, Tonin AM, Busanello EN, Pettenuzzo LF, Netto CA, Wajner M. 2009. Chronic early postnatal administration of ethylmalonic acid to rats causes behavioral deficit. Behav Brain Res 197: 364-370.
38. Schuck PF, Busanello EN, Moura AP, Tonin AM, Grings M, Ritter L, Vargas CR, Ferreira da C, Wajner M. 2010. Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid. Neurochem Res 35: 298-305.
39. Sweadner KJ. 1979. Two molecular forms of Na(+) K(+)-stimulated ATPase in brain. Separation, and difference in affinity for strophanthidin. J Biol Chem 254: 6060-6067.
40. Stefanello FM, Ferreira AG, Pereira TC, da Cunha MJ, Bonan CD, Bogo MR, Wyse AT. 2011. Acute and chronic hypermethioninemia alter Na(+), K(+)-ATPase activity in rat hippocampus: Prevention by antioxidants. Int J Dev Neurosci 29: 483-488.
41. Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, Goodlett D, Berger JP, Gunter B, Linseley PS, Stoughton RB, Aebersold R, Collins SJ, Hanlon WA, Hood LE. 2004. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Proteomics 3: 960-969.
42. Tiranti V, D'Adamo P, Briem E, Ferrari G, Mineri R, Lamantea E, Mandel H, Balestri P, Garcia-Silva MT, Vollmer B, Rinaldo P, Hahn SH, Leonard J, Rahman S, Dionisi-Vici C, Garavaglia B, Gasparini P, Zeviani M. 2004. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74: 239-252.
43. Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C, Levitt MD, Prelle A, Fagiolari G, Rimoldi M, Zeviani M. 2009. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15: 200-205.
44. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem J 220: 301-307.
45. Viscomi C, Burlina AB, Dweikat I, Savoiardo M, Lamperti C, Hildebrandt T, Tiranti V, Zeviani M. 2010. Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16: 869-871.
46. Walsh DJ, Sills ES, Lambert DM, Gregersen N, Malone FD, Walsh AP. 2010. Novel ETHE1 mutation in a carrier couple having prior offspring affected with ethylmalonic encephalopathy: Genetic analysis, clinical management and reproductive outcome. Mol Med Report 3: 223-226.
47. Washburn MP, Koller A, Oshiro G, Ulaszek RR, Plouffe D, Deciu C, Winzeler E, Yates JRIII. 2003. Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 100: 3107-3112.
48. Zannolli R, Buoni S, Tassini M, De Nicola A, Betti G, De Felice C, Orsi A, Varetti MC, Ferrara F, Messina M, Giannini C, Mohn A, Chiarelli F, Liberati M, Strambi M, Funghini S, Vivi A, Wevers RA, Hayek J. 2010. Silent increase of urinary ethylmalonic acid is an indicator of nonspecific brain dysfunction. NMR Biomed 23: 353-358.
49. Zolkipli Z, Pedersen CB, Lamhonwah AM, Gregersen N, Tein I. 2011. Vulnerability to oxidative stress in vitro in pathophysiology of mitochondrial short-chain acyl-CoA dehydrogenase deficiency: Response to antioxidants. PLoS One 6: e17534.